Question 1

What is the catalog number for Putative nascent Polypeptide-associated complex subunit α-Like protein (NACAP1) Human ELISA Kit?

Accepted Answer

The catalog number for Putative nascent Polypeptide-associated complex subunit α-Like protein (NACAP1) Human ELISA Kit is G5413.

Question 2

What sizes are available for Putative nascent Polypeptide-associated complex subunit α-Like protein (NACAP1) Human ELISA Kit?

Accepted Answer

Putative nascent Polypeptide-associated complex subunit α-Like protein (NACAP1) Human ELISA Kit is available in the following size(s): 96 Tests.

Question 3

Is Putative nascent Polypeptide-associated complex subunit α-Like protein (NACAP1) Human ELISA Kit in stock?

Accepted Answer

Putative nascent Polypeptide-associated complex subunit α-Like protein (NACAP1) Human ELISA Kit is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 5

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 6

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Putative nascent Polypeptide-associated complex subunit α-Like protein (NACAP1) Human ELISA Kit

Product Specifications

Frequently Asked Questions

Explore Other Products

NAT14 Antibody (N-term) [APR30578G]

NAT14 Antibody (N-term) [APR30578G]

NAT14 Antibody (N-term) [APR30578G]

NAT14 Antibody (N-term) [APR30578G]

FXR1 Knockout HT29 Polyclonal Cells

ETFA sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)